Do we need more drugs to treat Parkinson's disease?
Weiner, W.J.; Shulman, L.M.; Oertel, W.H.
Advances in Neurology 80: 481-483
1999
ISSN/ISBN: 0091-3952 PMID: 10410759 Document Number: 504998
Document emailed within 1 workday
Related Documents
Hasegawa, K. 2000: The new Parkinson's disease drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 58(10): 2066-2071Johnston, T.H.; Brotchie, J.M. 2004: Drugs in development for Parkinson's disease Current Opinion in Investigational Drugs 5(7): 720-726
Korczyn, A.D. 2003: Dopaminergic drugs in development for Parkinson's disease Advances in Neurology 91: 267-271
Johnston, T.H.; Brotchie, J.M. 2006: Drugs in development for Parkinson's disease: an update Current Opinion in Investigational Drugs 7(1): 25-32
Meco, G.; Casacchia, M.; Lazzari, R.; Franzese, A.; Castellana, F.; Carta, A.; Iannuccelli, M.; Agnoli, A. 1984: Mental impairment in Parkinson's disease. the role of anticholinergic drugs Acta Psychiatrica Belgica 84(4): 325-335
Prabhakar, S.; Syal, P.; Srivastava, T. 2000: P300 in newly diagnosed non-dementing Parkinson's disease: effect of dopaminergic drugs Neurology India 48(3): 239-242
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Martínez-Suárez, M.M.; Blázquez-Menes, B. 2000: Estimation of the prevalence of Parkinson's disease in Asturia, Spain. a pharmacoepidemiological study of the consumption of antiparkinson drugs Revista de Neurologia 31(11): 1001-1006
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Wynn, R.L.; Meiller, T.F. 2000: Artificial saliva products and drugs to treat xerostomia General Dentistry 48(6): 630-636
Vasil'eva, I.S.; Muzyra, I.A.; Lysak, L.S.; Tikhonova, L.A.; Efron, I.I. 1982: Cost of drugs used to treat patients in tuberculosis hospitals Problemy Tuberkuleza 10: 14-17
Vilaseca Canais, J.; Buxeda Mestres, C.; Cámara Contreras, C.; Flor Serra, F.; Pérez Guinaldo, R.; Sánchez Viñas, M. 1997: Do the patients we treat with hypolipemic drugs have a coronary risk? Atencion Primaria 20(1): 49-53
Gadakh, B.; Van Aerschot, A. 2015: Renaissance in Antibiotic Discovery: Some Novel Approaches for Finding Drugs to Treat Bad Bugs Current Medicinal Chemistry 22(18): 2140-2158
Leon, M.-M.; Mitu, F. 2013: The clinical-epidemological study of drugs used to treat arterial hypertension and associated comorbidities Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 117(2): 488-494
Zhong, L.; Hong, H. 2005: Dr. Chen Xiangjun's experience in using pair of drugs to treat rheumatic diseases Journal of Traditional Chinese Medicine 25(4): 282-289
Akcali, A.; Savas, L. 2008: Malignant syndrome of two Parkinson patients due to withdrawal of drugs Annals of the Academy of Medicine Singapore 37(1): 77-78
Aquilonius, S.M.; Hartvig, P. 1980: Survey of the prescription of anti-parkinson drugs in Sweden during the seventies Lakartidningen 77(30-31): 2594-2595
Hopper, A.H. 1995: Non-steroidal anti-inflammatory drugs in elderly people. Treat mild chronic pain with paracetamol initially Bmj 311(7001): 391; Author Reply 392